Literature DB >> 10849264

Do undefined sources of hepatitis C transmission exist? The Greek study in General Practice.

C Lionis1, I G Vlachonikolis, S Skliros, A Symeonidis, B P Merkouris, E Kouroumalis.   

Abstract

A seroepidemiological study was carried out in 15 primary health care (PHC) centres in rural Greece to determine the prevalence of hepatitis C virus (HCV) in the surgeries of Greek General Practitioners (GPs) and to further clarify the transmission of hepatitis C in Greece. Serum samples were obtained from 1961 subjects (1259 females) aged >/= 15 years, who visited GP surgeries between July 1996 and February 1997 in 15 PHC centres located in three large Greek regions (Macedonia, Attika and Crete). Subjects who participated in the study fulfilled the following criteria: history of blood transfusion; hospital admission of > 7 days' duration without surgical or other intervention; use of intravenous drugs (current or previous); or women with a history of medical or paramedical abortion. Nearly 65% (1263 subjects) of the participants in this study reported hospital admission with a length of stay > 7 days. Antibodies to HCV (anti-HCV) were found in 67 participants (3. 5%), 41 of whom were females and 44 of whom were aged >/= 61 years. The highest prevalence (4.8%) of anti-HCV was found in Crete, and differences among the Greek regions were statistically significant (P < 0.05). Multivariate statistical analysis showed that in addition to regional differences, the following variables had a statistically significant effect on the prevalence of anti-HCV: history of dental surgery; use of intravenous drugs; hospital admission for > 7 days; and the high consumption of alcoholic drinks. Hence there is a significant variability in the prevalence of hepatitis C in well-defined PHC areas of Greece. Several risk factors for acquiring HCV infection have been identified. Screening for HCV risk factors may enable Greek GPs to identify HCV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849264     DOI: 10.1046/j.1365-2893.2000.00217.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  6 in total

1.  Impact of hepatitis B and hepatitis C virus infections in a hematology-oncology unit at a children's hospital in Nicaragua, 1997 to 1999.

Authors:  Kirsten Visoná; Fulgencio Baez; Lizeth Taylor; René Berríos; Bernal León; Carlos Pacheco; Roberto Jirón; Ronald B Luftig; M Mercedes Somarriba
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  Prevalence of hepatitis B and C markers in high-risk hospitalised patients in Crete: a five-year observational study.

Authors:  M Koulentaki; M Ergazaki; J Moschandrea; S Spanoudakis; N Tzagarakis; P E Drandakis; D A Spandidos; E A Kouroumalis
Journal:  BMC Public Health       Date:  2001-12-21       Impact factor: 3.295

3.  Low prevalence of liver-kidney microsomal autoantibodies of type 1 (LKM1) in hepatitis C seropositive subjects on Crete, Greece.

Authors:  D Drygiannakis; C Lionis; I Drygiannakis; G Pappas; E Kouroumalis
Journal:  BMC Gastroenterol       Date:  2001-06-11       Impact factor: 3.067

4.  Prioritizing High-Risk Practices and Exploring New Emerging Ones Associated With Hepatitis C Virus Infection in Egypt.

Authors:  Ammal Metwally; Amira Mohsen; Rehan Saleh; Walaa Foaud; Nihad Ibrahim; Thanaa Rabaah; Manal El-Sayed
Journal:  Iran J Public Health       Date:  2014-10       Impact factor: 1.429

Review 5.  Hepatitis C virus: A critical approach to who really needs treatment.

Authors:  Elias Kouroumalis; Argyro Voumvouraki
Journal:  World J Hepatol       Date:  2022-01-27

Review 6.  Epidemiology of hepatitis C in Greece.

Authors:  Christos Triantos; Christos Konstantakis; Paraskeui Tselekouni; Maria Kalafateli; Ioanna Aggeletopoulou; Spilios Manolakopoulos
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.